Cullinan Therapeutics, Inc. (CGEM)
NASDAQ: CGEM · Real-Time Price · USD
7.50
-0.52 (-6.48%)
Mar 31, 2025, 1:37 PM EDT - Market open

Cullinan Therapeutics Statistics

Total Valuation

CGEM has a market cap or net worth of $438.85 million. The enterprise value is $31.20 million.

Market Cap 438.85M
Enterprise Value 31.20M

Important Dates

The next estimated earnings date is Wednesday, May 14, 2025, after market close.

Earnings Date May 14, 2025
Ex-Dividend Date n/a

Share Statistics

CGEM has 58.51 million shares outstanding. The number of shares has increased by 29.41% in one year.

Current Share Class 58.51M
Shares Outstanding 58.51M
Shares Change (YoY) +29.41%
Shares Change (QoQ) +0.42%
Owned by Insiders (%) 4.02%
Owned by Institutions (%) 83.65%
Float 38.98M

Valuation Ratios

PE Ratio n/a
Forward PE n/a
PS Ratio n/a
Forward PS n/a
PB Ratio 0.79
P/TBV Ratio 0.73
P/FCF Ratio n/a
P/OCF Ratio n/a
PEG Ratio n/a
Financial Ratio History

Enterprise Valuation

EV / Earnings n/a
EV / Sales n/a
EV / EBITDA n/a
EV / EBIT n/a
EV / FCF n/a

Financial Position

The company has a current ratio of 13.53, with a Debt / Equity ratio of 0.00.

Current Ratio 13.53
Quick Ratio 13.23
Debt / Equity 0.00
Debt / EBITDA n/a
Debt / FCF n/a
Interest Coverage n/a

Financial Efficiency

Return on equity (ROE) is -32.10% and return on invested capital (ROIC) is -23.44%.

Return on Equity (ROE) -32.10%
Return on Assets (ROA) -22.26%
Return on Invested Capital (ROIC) -23.44%
Return on Capital Employed (ROCE) -33.31%
Revenue Per Employee n/a
Profits Per Employee -$1.51M
Employee Count 111
Asset Turnover n/a
Inventory Turnover n/a

Taxes

In the past 12 months, CGEM has paid $117,000 in taxes.

Income Tax 117,000
Effective Tax Rate n/a

Stock Price Statistics

The stock price has decreased by -57.07% in the last 52 weeks. The beta is -0.11, so CGEM's price volatility has been lower than the market average.

Beta (5Y) -0.11
52-Week Price Change -57.07%
50-Day Moving Average 9.27
200-Day Moving Average 14.24
Relative Strength Index (RSI) 29.59
Average Volume (20 Days) 400,445

Short Selling Information

The latest short interest is 8.67 million, so 14.83% of the outstanding shares have been sold short.

Short Interest 8.67M
Short Previous Month 8.66M
Short % of Shares Out 14.83%
Short % of Float 22.25%
Short Ratio (days to cover) 19.85

Income Statement

Revenue n/a
Gross Profit n/a
Operating Income -196.92M
Pretax Income -156.28M
Net Income -167.38M
EBITDA -196.61M
EBIT -196.92M
Earnings Per Share (EPS) -$3.11
Full Income Statement

Balance Sheet

The company has $398.98 million in cash and $2.15 million in debt, giving a net cash position of $396.83 million or $6.78 per share.

Cash & Cash Equivalents 398.98M
Total Debt 2.15M
Net Cash 396.83M
Net Cash Per Share $6.78
Equity (Book Value) 590.33M
Book Value Per Share 10.09
Working Capital 384.02M
Full Balance Sheet

Cash Flow

Operating Cash Flow -145.30M
Capital Expenditures n/a
Free Cash Flow -145.30M
FCF Per Share -$2.48
Full Cash Flow Statement

Margins

Gross Margin n/a
Operating Margin n/a
Pretax Margin n/a
Profit Margin n/a
EBITDA Margin n/a
EBIT Margin n/a
FCF Margin n/a

Dividends & Yields

CGEM does not appear to pay any dividends at this time.

Dividend Per Share n/a
Dividend Yield n/a
Dividend Growth (YoY) n/a
Years of Dividend Growth n/a
Payout Ratio n/a
Buyback Yield -29.41%
Shareholder Yield -29.41%
Earnings Yield -39.11%
FCF Yield -33.95%

Analyst Forecast

The average price target for CGEM is $32.86, which is 338.13% higher than the current price. The consensus rating is "Strong Buy".

Price Target $32.86
Price Target Difference 338.13%
Analyst Consensus Strong Buy
Analyst Count 8
Revenue Growth Forecast (5Y) n/a
EPS Growth Forecast (5Y) -2.38%
Stock Forecasts

Stock Splits

This stock does not have any record of stock splits.

Last Split Date n/a
Split Type n/a
Split Ratio n/a

Scores

Altman Z-Score n/a
Piotroski F-Score 1